37
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T25196 |
BZAD01
BZAD-01,BZAD 01 |
NMDAR | Neuroscience |
BZAD01 是一种选择性 NMDA NR1A/2B 受体拮抗剂。 | |||
T22674 |
Co 101244 hydrochloride
Co 101244盐酸盐,4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride |
NMDAR | Neuroscience |
Co 101244 hydrochloride (4-Piperidinol, 1-[2-(4-hydroxyphenoxy)ethyl]-4-[(4-Methylphenyl)Methyl]-,hydrochloride) 是一种含有 NR2B 的 NMDA 受体拮抗剂。 | |||
T13112L1 |
Tat-NR2B9c acetate
Tat-NR2B9c acetate (500992-11-0 Free base),NA-1 acetate |
Others | Others |
Tat-NR2B9c acetate (NA-1 acetate) 是一种突触后密度 95 (PSD-95) 抑制剂,对 PSD-95d2 (PSD-95 PDZ domain 2) 和 PSD-95d1 的 EC50 值分别为 6.7 nM 和 670 nM。它破坏 PSD-95/NMDAR 相互作用,抑制 NR2A 和 NR2B 与 PSD-95 的结合,IC50 值分别为 0.5 μM 和 8 μM。它还抑制神经元一氧化氮合酶 (nNOS)/PSD-95 相互作用,并具有神经保护功效。 | |||
T81037 |
Tat-HA-NR2B9c
|
||
Tat-HA-NR2B9 是一种包括HIV-1 Tat细胞膜转导结构域片段、流感病毒血凝素(HA)表位标签以及NR2B(NR2B9c) C端9个氨基酸的化学复合物。该化合物能够降低大鼠缺血性脑损伤的梗塞面积,同时促进神经功能的恢复。 | |||
T35924 |
Tat-NR2Baa
Tat-NR2Baa |
||
Tat-NR2BAA is an inactive control peptide of Tat-NR2B9c. It shares a similar sequence with Tat-NR2B9c, but possesses a double-point mutation in the COOH terminal tSXV motif. This mutation renders Tat-NR2BAA unable to bind PSD-95. Tat-NR2B9c, on the other hand, is a membrane-permeable peptide that interferes with PSD-95/NMDAR binding. This interference leads to the decoupling of NR2B- and/or NR2A-type NMDARs from PSD-95[1][2]. | |||
T76069 |
Tat-NR2Baa TFA
|
||
Tat-NR2BAA TFA 是 Tat-NR2B9c 的对照肽 (control peptide),没有活性。Tat-NR2BAA TFA 的序列与 Tat-NR2B9c 相似,但在 COOH 末端 tSXV 基序中有一个双点突变,这使得它无法结合 PSD-95。Tat-NR2B9c TFA 是一种可通透细胞膜的多肽,破坏 PSD-95/NMDAR 的结合。 | |||
T13112L |
Tat-NR2B9c TFA
NA-1 (TFA) |
Others | Others |
Tat-NR2B9c TFA is a 20-aa peptide, and acts as an inhibitor of postsynaptic density-95 (PSD-95)(EC50 of 6.7 nM for PSD-95d2), and possesses neuroprotective efficacy. | |||
T13112 |
Tat-NR2B9c
Tat-NR2Bct,NA-1 |
NO Synthase; iGluR | Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience |
Tat-NR2B9c (NA-1) 是一种突触后密度-95(PSD-95)抑制剂,具有神经保护和抗癫痫作用。Tat-NR2B9c 可抑制PSD-95d2、 PSD-95d1 和 PSD-95,可阻止NMDA诱导的神经元NADPH氧化酶的激活,从而阻断超氧化物的产生,可减少中风后急性期的缺血性损伤。 | |||
T5385 |
Radiprodil
RGH-896 |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
Radiprodil (RGH-896) 是一种具有口服活性的、NMDA 受体 NR2B 亚类的选择性拮抗剂。它有用于神经性疼痛和其它慢性疼痛的相关研究潜力。 | |||
T1751 |
Eliprodil
依利罗地,SL-820715 |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
Eliprodil (SL-820715) 是NR2B-NMDA 受体高效选择性抑制剂,IC50值1uM。它对NR2A-和NR2C-NMDA 受体作用较弱,可用于研究帕金森病和运动障碍治疗的试验。 | |||
T23449 |
TCS 46b
|
NMDAR | Neuroscience |
TCS 46b 是一种具有口服活性的 NR1A/NR2B NMDA 受体拮抗剂。 | |||
T8920 |
Sepimostat
|
iGluR | Membrane transporter/Ion channel; Neuroscience |
Sepimostat 通过 NR2B 亚基的 Ifenprodil 结合位点的 NR2B N-甲基-D-天冬氨酸受体拮抗作用表现出神经保护活性。它抑制 Ifenprodil 结合的 Ki 值为27.7 µM。 | |||
T5522 |
NMDAR antagonist 1
|
Others; iGluR | Membrane transporter/Ion channel; Neuroscience; Others |
NMDAR antagonist 1 是一种 NR2B 选择性的、口服具有活力的 NMDAR 拮抗剂。 | |||
T12234 |
NMDA-IN-1
|
NMDAR | Neuroscience |
NMDA-IN-1是一种 NR2B 选择性 NMDA 拮抗剂,对NMDA 的Ki 值为 0.85 nM,对NR2B Ca2+ influx 的IC50值为 9.7 nM。 | |||
T12758 |
Ro 25-6981
|
NMDAR | Neuroscience |
Ro 25-6981 是一种有效的选择性活性依赖性 NMDA 受体阻滞剂,含有 NR2B 亚基,对克隆受体亚基组合 NR1C/NR2B 和 NR1C/NR2A 的 IC50 分别为 0.009 和 52 μM。 Ro 25-6981 可用于帕金森病的研究。 | |||
T8450 |
TCN 213
TCN213 |
NMDAR | Neuroscience |
TCN 213 是一种可克服的(surmountable)、甘氨酸依赖的 GluN1/GluN2A NMDAR 选择性拮抗剂,当甘氨酸的含量为75、 750、7500 nM 时,IC50s 值分别为 0.55、3.5、40 μM。它可用于在药理学上监测 NMDAR 表达在发育中的皮层神经元中的转换。 | |||
T40999 | NMDA receptor antagonist 2 | ||
NMDA receptor antagonist 2 is a highly potent and orally active NR2B subtype-selective antagonist of the N-methyl-D-aspartate (NMDA) receptor. It exhibits remarkable binding affinities, with an IC50 of 1.0 nM and a Ki value of 0.88 nM. This compound finds valuable application in scientific investigations focusing on neuropathic pain and Parkinson’s disease. | |||
T23457 | threo Ifenprodil hemitartrate | Others | Others |
σ receptor agonist and NR2B subunit-selective NMDA receptor antagonist | |||
T23239 | Ro 04-5595 hydrochloride | Others | Others |
NR2B-containing NMDA receptors antagonist | |||
T31046 |
CP-283097
CP283097,UNII-WHL1Z3GN15,CP 283097 |
||
CP-283097 is an N-methyl-D-aspartic acid (NMDA) receptor antagonist with NR2B subunit. | |||
T70055 |
CO-101244 Free Base
|
||
CO-101244 Free Base is an NMDA receptor NR2B subunit blocker. | |||
T24717 |
Ro 25-6981 HCl
Ro 25 6981 HCl |
||
Ro 25-6981 HCl is an effective and selective NMDA glutamate receptors containing the NR2B subunit antagonist. | |||
T30428 |
Besonprodil
Besonprodil (USAN),UNII-5K3N2D15WW,253450-09-8,CHEMBL219631,CI-1041 |
||
Besonprodil is a drug that acts as an NMDA antagonist and is selective for the NR2B subunit. | |||
T12758L |
Ro 25-6981 Maleate
|
Others | Others |
Ro 25-6981 Maleate is a potent and selective activity-dependent NMDA receptors blocker containing the NR2B subunit.(IC50 values are 0.009 and 52 μM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respectively). | |||
TQ0233L |
Traxoprodil Mesylate
|
||
Traxoprodil Mesylate is a potent noncompetitive N-methyl-D-aspartate (NMDA) receptors antagonist and has selective for the NR2B subunit. | |||
T70049 |
Ro 04-5595 free base
|
||
Ro 04-5595 is a selective antagonist of NMDA receptors NR2B subunits. Ro 04-5595 had an EC 50 of 186 ± 32 nmol/L. Ro 04-5595 was predicted to bind the EVT-101 binding site, not the ifenprodil-binding site. Specific binding, defined with a new NR2B-specific antagonist Ro 04-5595 at 10 microM was fully inhibited by several compounds with the following rank order of affinities--Ro 25-6981 > CP-101,606 > Ro 04-5595 = ifenprodil >> eliprodil > haloperidol > spermine > spermidine > MgCl2 > CaCl2--and... | |||
T62126 | (Rac)-NMDAR antagonist 1 | ||
(Rac)-NMDAR antagonist 1 是一种 NMDAR antagonist 1 的消旋体。其中 NMDAR antagonist 1 是一种有效的、口服具有活力的、NR2B 选择性的 NMDAR 拮抗剂。 | |||
T37096 | Sepimostat dimethanesulfonate | ||
Sepimostat dimethanesulfonate (FUT-187) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat dimethanesulfonate inhibits the Ifenprodil binding with a Ki value of 27.7 μM[1]. Sepimostat (1 to 100 nmol/eye, intravitreal injection) exhibits significant neuroprotective effect[1]. ... | |||
T68255 | CJ 036878 | ||
CJ 036878 was developed as an antagonist of the N-methyl-D-aspartate receptor NR2B subunit. | |||
T23809 |
BMT-108908
BMT108908 |
||
BMT-108908 is a Negative Allosteric Modulator. It is selective for the NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains. | |||
T61319 |
Onfasprodil
|
||
Onfasprodil, a negative allosteric modulator of NR2B, has been identified as a potential compound for researching Alzheimer's disease. This compound, in combination with a GABA receptor regulator.[1] | |||
TP2060 |
Conantokin G
|
||
GluN2B (formally NR2B) selective, competitive antagonist of the NMDA receptor. Blocks NMDA-evoked current in mouse cortical neurons (IC50 = 480 nM); also inhibits NMDA-evoked responses in oocytes expressing GluN2B (formally NR2B), but not GluN2A (formally | |||
T68973 | EVT-101 free base | ||
EVT-101, also known as ENS-101, is an experimental medication which originated from Roche and is under development by Evotec AG for the treatment of major depressive disorder. It acts as a selective NMDA receptor subunit 2B (NR2B) antagonist. | |||
T41058 |
Nelonemdaz potassium
Neu2000potassium,Salfaprodil |
||
Nelonemdaz potassium (also known as Salfaprodil) is a potent NR2B-selective and uncompetitive antagonist of N-methyl-D-aspartate (NMDA). This compound exhibits remarkable neuroprotection against cell death induced by both NMDA and free radicals, in addition to its role as a free radical scavenger. | |||
T83731 |
Tat-CBD3 TFA
|
||
Tat-CBD3是一种抑制N型电压门控钙通道Cav2.2与collapsin response mediator protein 2 (CRMP2)之间的蛋白质-蛋白质相互作用的抑制剂。它还能抑制CRMP2与NMDA受体NR2B亚单位之间的蛋白质-蛋白质相互作用。在无细胞实验中,Tat-CBD3 (10 µM)能将Cav2.2-CRMP2相互作用抑制43%,并在免疫共沉淀实验中抑制NMDA受体NR2B亚单位-CRMP2相互作用。它能在初级大鼠背根神经节 (DRG) 神经元中减少约60%的电压诱导钙电流,并在初级大鼠海马神经元中减少谷氨酸诱导的胞内钙水平增加。Tat-CBD3 (20 mg/kg)在大鼠中脑动脉闭塞 (MCAO) 引发的脑缺血模型中减少梗死体积。鞘内给药Tat-CBD3 (20 µg/5 µl)可防止大鼠卡拉胶诱导的热敏感性。 | |||
T37671 |
CAY10608
CAY10608 |
||
N-Methyl-D-aspartate (NMDA) receptors are Ca2+ permeable ligand-gated channels of the central nervous system that are activated after binding of the co-agonists glutamate and glycine. CAY10608 is a propanolamine that potently, selectively, and non-competitively antagonizes the NR2B subunit of NMDA receptors (IC50 = 50 nM). It does not inhibit NR1, NR2A, NR2C, and NR2D subunits and has no significant effects on α-amino-3-hydroxy-5-methyl-4-isoxazolepropioinic acid (AMPA) or kainate receptors. CAY... | |||
T37215 |
5α,6β-Dihydroxycholestanol
|
||
5α,6β-Dihydroxycholestanol is an oxysterol metabolite of cholesterol formed from conversion of cholesterol epoxides by 5,6-epoxysterol hydrolase. It inhibits NMDA-mediated calcium influx in HEK293 cells expressing NR1/NR2B NMDA receptors in a concentration-dependent manner. It also binds to voltage-gated sodium (Nav) channels and decreases action potentials in hippocampal neurons in vitro when used at a concentration of 10 uM. It increases survival of spinal cord motoneurons, cortical neurons, a... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1186 |
Ifenprodil Tartrate
|
Potassium Channel; NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
Ifenprodil tartrate 是典型的非竞争性 NMDA 受体拮抗剂,抑制 GIRK (Kir3),通过基底 GIRK 活性减少内向电流,有用做脑血管舒张试剂的潜力。它对 NR1A/NR2B 受体亲和力是 NR1A/NR2A 受体的 400 倍。 |